Item 8.01. Other Events.

On July 31, 2008, Bristol-Myers Squibb Company ("BMS") filed a Form 8-K attaching a press release announcing its proposal to enter into an agreement to acquire ImClone Systems Incorporated ("ImClone") for $60 per share in cash. As stated in the press release, BMS conducted an investor relations conference call on July 31, 2008 at 8:30 a.m., (EDT), to discuss the proposed acquisition of ImClone. Both the audio web cast replay and a written transcript of the conference are now available on www.bms.com/ir. The transcript of the conference call is attached as Exhibit 99.2 to this report and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

99.2. Transcript of the July 31, 2008 Investor Relations conference call.

---